A detailed history of National Bank Of Canada transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, National Bank Of Canada holds 2,506,741 shares of BMY stock, worth $145 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
2,506,741
Previous 2,506,741 -0.0%
Holding current value
$145 Million
Previous $130 Million -0.0%
% of portfolio
0.18%
Previous 0.18%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$39.66 - $51.75 $65.7 Million - $85.7 Million
1,656,141 Added 194.7%
2,506,741 $130 Million
Q2 2024

Aug 02, 2024

BUY
$40.25 - $52.99 $4.99 Million - $6.57 Million
123,938 Added 17.06%
850,600 $35.3 Million
Q1 2024

May 13, 2024

SELL
$47.98 - $54.4 $101 Million - $114 Million
-2,100,837 Reduced 74.3%
726,662 $39.4 Million
Q4 2023

Feb 06, 2024

BUY
$48.48 - $57.85 $64.3 Million - $76.7 Million
1,326,387 Added 88.36%
2,827,499 $145 Million
Q3 2023

Oct 10, 2023

BUY
$57.89 - $64.73 $10.6 Million - $11.9 Million
183,517 Added 13.93%
1,501,112 $87.1 Million
Q2 2023

Jul 26, 2023

BUY
$63.71 - $70.74 $24.4 Million - $27.1 Million
383,589 Added 41.07%
1,317,595 $84.3 Million
Q1 2023

Apr 12, 2023

SELL
$65.71 - $74.53 $12.3 Million - $14 Million
-187,940 Reduced 16.75%
934,006 $64.7 Million
Q4 2022

Jan 24, 2023

BUY
$68.48 - $81.09 $56.4 Million - $66.8 Million
824,324 Added 276.97%
1,121,946 $0
Q3 2022

Oct 13, 2022

SELL
$0.13 - $76.84 $9,750 - $5.76 Million
-75,006 Reduced 20.13%
297,622 $21.1 Million
Q2 2022

Jul 28, 2022

BUY
$72.62 - $79.98 $9.27 Million - $10.2 Million
127,640 Added 52.1%
372,628 $28.7 Million
Q1 2022

May 05, 2022

SELL
$61.48 - $73.72 $7.7 Million - $9.23 Million
-125,237 Reduced 33.83%
244,988 $18 Million
Q4 2021

Jan 24, 2022

BUY
$53.63 - $62.52 $19.9 Million - $23.1 Million
370,225 New
370,225 $23.1 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.